Section 1. Report Objective, and Methodology
- Scope of Research
- Research Methodology
- Assumptions
- Research Sources
- Primary Research
- Secondary Research
- Paid Sources
Section 2. Report Summary
- Global Market Snapshot, 2020-2030
- Executive Summary by Segments
- Market Overview, By Product Type
- Market Overview, By Technology
- Market Overview, By Disease Indication
- Market Overview, By Region
Section 3. Key Insights
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Developments
- Leading Brands
- Price Trend Analysis
- Pipeline Analysis
- Porter’s Analysis
- Epidemiology
- Technology Insights
- Impact of COVID-19
Section 4. Global Companion Diagnostics Market By Product Type, Market Size, and Revenue Opportunity (USD Billion, 2022-2030)
- Global Industry Overview, By Product Type
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Diagnostic Kits (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- Assays (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- Others (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
Section 5. Global Companion Diagnostics Market By Technology, Market Size, and Revenue Opportunity (USD Billion, 2022-2030)
- Global Industry Overview, By Technology
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- PCR (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- ISH (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- IHC (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- NGS (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
Section 6. Global Companion Diagnostics Market By Disease Indication, Market Size, and Revenue Opportunity (USD Billion, 2022-2030)
- Global Industry Overview, By Disease Indication
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Breast cancer (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- Lung cancer (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- Blood cancer (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- Colorectal cancer (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- Others (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
Section 7. Global Companion Diagnostics Market By Region, Market Size, and Revenue Opportunity (USD Billion, 2022-2030)
- Global Industry Overview, By Disease Indication
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- North America
- By Product Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Technology (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Disease Indication (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- U.S.
- Canada
- Latin America
- By Product Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Technology (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Disease Indication (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- Brazil
- Mexico
- Rest of Latin America
- Europe
- By Product Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Technology (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Disease Indication (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- By Product Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Technology (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Disease Indication (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- China
- Japan
- South Korea
- India
- ASEAN
- Rest of APAC
- Middle East and Africa
- By Product Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Technology (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Disease Indication (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Billion))
- Saudi Arabia
- UAE
- Rest of MEA
Section 8. Company Profiles
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Qiagen N.V.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- GE Healthcare
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Thermo Fischer Scientific
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Abbott Laboratories
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Guardant Health, Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Dako Denmark A/S
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Ventana Medical Systems, Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Biogenex Laboratories, Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Myriad Genetic Laboratories, Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
Frequently Asked Questions
The current market size of the Companion Diagnostics industry is approximately $5.6 billion.
Factors such as increasing demand for personalized medicine and rising prevalence of chronic diseases are contributing significantly to the growth of the Companion Diagnostics market.
Regulatory challenges and high development costs are key factors hampering the growth of the Companion Diagnostics Market.
The leading component segment in the Companion Diagnostics Market is the Assay Kits segment.
Major players operating in the Companion Diagnostics Market include Roche Diagnostics, Qiagen N.V., and Abbott Laboratories.
The CAGR of the Companion Diagnostics Market is projected to be around 12.3%, with a market size expected to reach $11.3 billion by 2030.